Princeton University Users: If you would like to view a senior thesis while you are away from campus, you will need to connect to the campus network remotely via the Global Protect virtual private network (VPN). If you are not part of the University requesting a copy of a thesis, please note, all requests are processed manually by staff and will require additional time to process.
 

Publication:

Immunomodulatory Imide Drugs Disrupt the Endogenous Chaperone Function of CRBN in a Novel Mechanism of Action

Loading...
Thumbnail Image

Files

RWY Thesis v4 references.pdf (9.32 MB)

Date

2025-04-14

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Abstract

Immunomodulatory drugs (IMiDs), including thalidomide, pomalidomide, and lenalidomide, are essential therapeutics for multiple myeloma (MM) throughout the course of treatment. However, most patients with MM eventually develop IMiD resistance and relapsed/refractory MM. Although IMiDs are known to target Cereblon (CRBN), an E3 ubiquitin ligase substrate receptor, and induce neo-substrate degradation of critical MM proteins, the mechanisms of resistance development and IMiD action are not fully understood. Here, novel endogenous interactors of CRBN identified via the µMap proximity labeling platform reveal a novel mechanism of action of IMiDs in inhibiting native CRBN co-chaperone function with heat shock proteins (HSPs). Independently of induced neo-substrate degradation, IMiDs destabilize CRBN interactors in lenalidomide-sensitive MM lines and increase apoptotic markers. In contrast, CRBN’s stabilization of proteins and nascent protein synthesis is maintained in lenalidomide-resistant MM lines, which attenuate the IMiD-mediated destabilization effect by upregulating critical HSPs. Combination treatment with HSP inhibitors and IMiDs can leverage this mechanism to sensitize IMiD-resistant MM cells to IMiD treatment. These data establish a novel mechanism of action and nominate native CRBN interactors and chaperone function as therapeutic targets for next-generation MM therapeutics.

Description

Keywords

Citation